Lovaza Related Published Studies
Well-designed clinical trials related to Lovaza (Omega-3-Acid Ethyl Esters)
Prescription omega-3-acid ethyl esters reduce fasting and postprandial triglycerides and modestly reduce pancreatic beta-cell response in subjects with primary hypertriglyceridemia. [2011.09]
Effects of prescription omega-3-acid ethyl esters on fasting lipid profile in subjects with primary hypercholesterolemia. [2011.04]
Effects of prescription omega-3-acid ethyl esters on fasting lipid profile in
subjects with primary hypercholesterolemia. [2011]
Effects of prescription omega-3-acid ethyl esters, coadministered with
atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein
CIII, and lipoprotein-associated phospholipase A2 mass in men and women with
mixed dyslipidemia. [2011]
Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients. [2010.04]
Effects of prescription omega-3-acid ethyl esters on non--high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin. [2010.02]
Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study. [2009.08]
Effect of omega-3-acid ethyl esters on the steady-state plasma pharmacokinetics of rosuvastatin in healthy adults. [2008.12]
Effect of omega-3-acid ethyl esters on steady-state plasma pharmacokinetics of atorvastatin in healthy adults. [2008.12]
Well-designed clinical trials possibly related to Lovaza (Omega-3-Acid Ethyl Esters)
Omega-3 Fatty Acids Do Not Improve Endothelial Function In Virologically Suppressed HIV-Infected Men: A Randomized Placebo-Controlled Trial. [2011.10.17]
Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial. [2010.12]
OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. [2010.11.23]
Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. [2009.10.21]
The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of treatment for very high triglyceride levels. [2009.09]
The rationale and design of the FORomegaARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation. [2009.03]
Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial. [2009.01]
Effects of Adding Prescription Omega-3 Acid Ethyl Esters to Simvastatin (20 mg/day) on Lipids and Lipoprotein Particles in Men and Women With Mixed Dyslipidemia. [2008.08.15]
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. [2007.07]
Other research related to Lovaza (Omega-3-Acid Ethyl Esters)
Long-term up to 24-month efficacy and safety of concomitant prescription
omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients. [2010]
Effects of prescription omega-3-acid ethyl esters on non--high-density
lipoprotein cholesterol when coadministered with escalating doses of
atorvastatin. [2010]
Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A(2) mass in statin-treated subjects with hypertriglyceridemia. [2009.10]
Prescription omega-3-acid ethyl esters for the treatment of very high triglycerides. [2009.07]
Omacor(R) (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia. [2009.07]
Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids. [2007.05]
Other possibly related research studies
Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia. [2009.05.29]
Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia. [2008.10.15]
PUFA for human health: diet or supplementation? [2009]
Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects. [2008.10]
Dispelling the myths about omega-3 fatty acids. [2008.07]
Optimal treatment for patients after myocardial infarction: some current concepts and controversies. [2008.01]
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. [2008.03]
[Hypertricglyceridemia: prognostic impact and treatment options]. [2011.07]
Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia. [2011]
Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. [2010.12]
[Effect of omega-3 acids on clinical evolution, plasma inflammatory biomarkers and B-type natriuretic peptide levels in patients with coronary heart disease]. [2011.05.14]
Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. [2010.08]
Omega-3 fatty acids do not improve endothelial function in virologically
suppressed HIV-infected men: a randomized placebo-controlled trial. [2012]
|
